Oxfam International Blog

News, opinion and debate from around the world and the web. Join the discussion.

As an Oxfam policy advisor on access to medicines, I believe governments have to take decisive action to reduce the price of new medicines to treat HIV and AIDS that are needed when HIV positive individuals develop resistance to first line treatments. These 2nd and 3rd line treatments, which are patented by big pharmaceutical companies, often cost five to ten times more than 1st line treatments for AIDS.

Mexico City abounds with life, but this week it´s even more abuzz. More than 25,000 people from around the world have come together to demand universal action now on HIV/AIDS and the energy is electric.

Activists and service providers, funders and researchers, big Pharma and sex workers, presidents and hairstylists have converged for the 17th International AIDS Conference, the first time the conference is being held in Latin America.


Subscribe to Blogs

Our Bloggers

Yeb Sano
Climate Change Commissioner, Philippines
Sarah Best
Oxfam Great Britain
Policy Adviser - Low Carbon Development
Augustino Buya
Oxfam Great Britain
Program Manager in Western Equatoria (Southern Sudan)
Kanayo F. Nwanze
President of the International Fund for Agricultural Development (IFAD)